We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights BHP Group, AstraZeneca, The Boeing, Diageo and General Mills
Read MoreHide Full Article
For Immediate Release
Chicago, IL – July 10, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: BHP Group Limited (BHP - Free Report) , AstraZeneca PLC (AZN - Free Report) , The Boeing Company (BA - Free Report) , Diageo plc (DEO - Free Report) and General Mills, Inc. (GIS - Free Report)
Here are highlights from Friday’s Analyst Blog:
Top Analyst Reports for BHP Group, AstraZeneca and Boeing
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including BHP Group Limited, AstraZeneca PLC and The Boeing Company. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of BHP Group have outperformed the Zacks Mining - Miscellaneous industry over the past year (+19.1% vs. +6.3%) as the company's leverage to the prospect of Chinese fiscal stimulus through its iron ore production outlook.
The company's iron ore production guidance for fiscal 2023 is 249-260 Mt, indicating 1% year-over-year growth at the midpoint. Iron ore prices had earlier lost steam on weak demand in China due to the slump in property investment while supply prospects remained strong.
However, the possibility that the Chinese government will provide stimulus measures for its construction sector has helped lift up iron ore prices lately. Going forward, iron ore prices are expected to be supported by demand in the automotive sector, infrastructure and housing market.
Copper and nickel prices will also be fueled by growing demand for electric vehicles. BHP's investment in growth projects with focus on commodities like copper, nickel and potash will aid growth. Its efforts to make operations more efficient through technology adoption will drive earnings.
AstraZeneca shares have underperformed the Zacks Large Cap Pharmaceuticals industry over the past year (-0.4% vs. +8.6%). The company's diabetes franchise faces stiff competition while pricing pressure hurts sales in the respiratory unit. Sales are slowing down in its key market, China. Estimate movements have been mixed ahead of Q2 results.
Nevertheless, AstraZeneca has reported impressive earnings surprise in recent quarters. Its key drugs, mainly cancer medicines, Lynparza, Tagrisso and Imfinzi should keep driving revenues. Its pipeline is strong with several phase III data readouts lined up for 2023.
It has also been engaged in external acquisitions and strategic collaborations to boost its pipeline while investing in geographic areas of high growth like emerging markets. Cost-cutting efforts should drive earnings. The Alexion buyout strengthened its immunology franchise, adding several drugs that are boosting its top line.
Shares of Boeing have outperformed the Zacks Aerospace - Defense industry over the past year (+53.2% vs. +0.7%). The company remains the largest aircraft manufacturer in the United States, in terms of revenues, orders and deliveries. Lately, the company has been witnessing a solid recovery in its commercial business.
During the first quarter, the company booked 107 net commercial airplane orders. The U.S. government's inclination toward strengthening the nation's defense system should also boost Boeing's growth. The company holds a strong solvency position in the near term.
However, its 737 MAX program remains a cause of concern in China, thereby impacting its expectation of delivery timing and future gradual production rate increases. Boeing continues to incur notable abnormal production cost in relation to production quality issues for 787 jets, which may hurt its future results.
Other noteworthy reports we are featuring today include Diageo plc and General Mills, Inc..
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights BHP Group, AstraZeneca, The Boeing, Diageo and General Mills
For Immediate Release
Chicago, IL – July 10, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: BHP Group Limited (BHP - Free Report) , AstraZeneca PLC (AZN - Free Report) , The Boeing Company (BA - Free Report) , Diageo plc (DEO - Free Report) and General Mills, Inc. (GIS - Free Report)
Here are highlights from Friday’s Analyst Blog:
Top Analyst Reports for BHP Group, AstraZeneca and Boeing
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including BHP Group Limited, AstraZeneca PLC and The Boeing Company. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Shares of BHP Group have outperformed the Zacks Mining - Miscellaneous industry over the past year (+19.1% vs. +6.3%) as the company's leverage to the prospect of Chinese fiscal stimulus through its iron ore production outlook.
The company's iron ore production guidance for fiscal 2023 is 249-260 Mt, indicating 1% year-over-year growth at the midpoint. Iron ore prices had earlier lost steam on weak demand in China due to the slump in property investment while supply prospects remained strong.
However, the possibility that the Chinese government will provide stimulus measures for its construction sector has helped lift up iron ore prices lately. Going forward, iron ore prices are expected to be supported by demand in the automotive sector, infrastructure and housing market.
Copper and nickel prices will also be fueled by growing demand for electric vehicles. BHP's investment in growth projects with focus on commodities like copper, nickel and potash will aid growth. Its efforts to make operations more efficient through technology adoption will drive earnings.
(You can read the full research report on BHP Group here >>>)
AstraZeneca shares have underperformed the Zacks Large Cap Pharmaceuticals industry over the past year (-0.4% vs. +8.6%). The company's diabetes franchise faces stiff competition while pricing pressure hurts sales in the respiratory unit. Sales are slowing down in its key market, China. Estimate movements have been mixed ahead of Q2 results.
Nevertheless, AstraZeneca has reported impressive earnings surprise in recent quarters. Its key drugs, mainly cancer medicines, Lynparza, Tagrisso and Imfinzi should keep driving revenues. Its pipeline is strong with several phase III data readouts lined up for 2023.
It has also been engaged in external acquisitions and strategic collaborations to boost its pipeline while investing in geographic areas of high growth like emerging markets. Cost-cutting efforts should drive earnings. The Alexion buyout strengthened its immunology franchise, adding several drugs that are boosting its top line.
(You can read the full research report on AstraZeneca here >>>)
Shares of Boeing have outperformed the Zacks Aerospace - Defense industry over the past year (+53.2% vs. +0.7%). The company remains the largest aircraft manufacturer in the United States, in terms of revenues, orders and deliveries. Lately, the company has been witnessing a solid recovery in its commercial business.
During the first quarter, the company booked 107 net commercial airplane orders. The U.S. government's inclination toward strengthening the nation's defense system should also boost Boeing's growth. The company holds a strong solvency position in the near term.
However, its 737 MAX program remains a cause of concern in China, thereby impacting its expectation of delivery timing and future gradual production rate increases. Boeing continues to incur notable abnormal production cost in relation to production quality issues for 787 jets, which may hurt its future results.
(You can read the full research report on Boeing here >>>)
Other noteworthy reports we are featuring today include Diageo plc and General Mills, Inc..
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.